Company profile

MBX Biosciences, Inc. Insider Trading

MBX

Every SEC Form 4 insider trading filing for MBX Biosciences, Inc. (MBX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001776111
Filings
70
Insiders
32
Last filing
2026-08-04

Activity summary

Recent insider activity is bullish. Over the last 30 days, 4 insiders purchased shares versus 1 sale. Buying was led by Smither John W.

Three year balance

Buy and sell value by quarter, Q3 24 to Q3 26. MBX Biosciences, Inc. insiders are net buyers across the period shown.

Q3 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $136.0M.

90 day insight

Over the last 90 days, MBX Biosciences, Inc. insiders bought $0 (11 transactions) and sold $24K (1 transaction).

  • Most active insider: Hoerter Steven L. with 3 transactions totaling $0.
  • Largest single sale: $24K by Azoulay Salomon on Aug 4, 2026.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 4, 2026Azoulay SalomonMBX
Sale
370$65.77$24K
Aug 3, 2026Smither John WMBX
Award
130,000
Aug 3, 2026Hoerter Steven L.MBX
Award
71,000
Aug 3, 2026Hoerter Steven L.MBX
Award
331,000
Aug 3, 2026Smither John WMBX
Award
28,000

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=MBX" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Heron Patrick J1 filing+$12.0M
Azoulay SalomonChief Medical Officer6 filings$1.9M
Hawryluk P. KentPresident & CEO5 filings+$1.8M
Hoerter Steven L.President and CEO1 filing+$265K
Pescovitz Ora H.1 filing+$45K

Institutional Ownership

Top 13F-HR holders of MBX Biosciences, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$439.7M
QoQ change
-71.1%
Reporting period
2026-06-30
#1
Nvp Associates, LLC
CIK 0001545692
$117.9M
2.1M shares
#2
BlackRock, Inc.
CIK 0002012383
$85.2M
1.5M shares
#3
Aaron Wealth Advisors LLC
CIK 0001812198
$64.5M
1.2M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →